| 000 | 01822 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250516234529.0 | ||
| 264 | 0 | _c20180118 | |
| 008 | 201801s 0 0 eng d | ||
| 022 | _a1436-3771 | ||
| 024 | 7 |
_a10.1007/s00784-014-1320-4 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHagelauer, Nadine | |
| 245 | 0 | 0 |
_aBisphosphonates inhibit cell functions of HUVECs, fibroblasts and osteogenic cells via inhibition of protein geranylgeranylation. _h[electronic resource] |
| 260 |
_bClinical oral investigations _cJun 2015 |
||
| 300 |
_a1079-91 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aBisphosphonate-Associated Osteonecrosis of the Jaw _xprevention & control |
| 650 | 0 | 4 |
_aBone Density Conservation Agents _xtoxicity |
| 650 | 0 | 4 |
_aCell Movement _xdrug effects |
| 650 | 0 | 4 |
_aCell Survival _xdrug effects |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 |
_aCyclohexenes _xpharmacology |
| 650 | 0 | 4 |
_aDiphosphonates _xtoxicity |
| 650 | 0 | 4 |
_aDiterpenes _xpharmacology |
| 650 | 0 | 4 |
_aEndothelial Cells _xdrug effects |
| 650 | 0 | 4 |
_aEugenol _xpharmacology |
| 650 | 0 | 4 |
_aFarnesol _xpharmacology |
| 650 | 0 | 4 |
_aFibroblasts _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImidazoles _xtoxicity |
| 650 | 0 | 4 | _aLimonene |
| 650 | 0 | 4 |
_aMenthol _xpharmacology |
| 650 | 0 | 4 |
_aOsteogenesis _xdrug effects |
| 650 | 0 | 4 | _aProtein Prenylation |
| 650 | 0 | 4 | _aRecurrence |
| 650 | 0 | 4 |
_aSqualene _xpharmacology |
| 650 | 0 | 4 |
_aTerpenes _xpharmacology |
| 650 | 0 | 4 |
_aUmbilical Veins _xcytology |
| 650 | 0 | 4 | _aZoledronic Acid |
| 700 | 1 | _aZiebart, Thomas | |
| 700 | 1 | _aPabst, Andreas M | |
| 700 | 1 | _aWalter, Christian | |
| 773 | 0 |
_tClinical oral investigations _gvol. 19 _gno. 5 _gp. 1079-91 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00784-014-1320-4 _zAvailable from publisher's website |
| 999 |
_c24227724 _d24227724 |
||